CytoDyn to Present at Wall Street Reporter’s “
Post# of 146090
![Avatar](/images/ProfileImages/167738657_59587_mando klein.jpg)
CytoDyn to Present at Wall Street Reporter’s “NEXT SUPER STOCK” Livestream Event on April 17, 2020 at 12:30 pm ET / 9:30 am PT
Download as PDFApril 16, 2020 6:00am EDT
VANCOUVER, Washington, April 16, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"
![](/images/icons/icon_wink.gif)
Date: Friday, April 17, 2020
Time: 12:30 pm ET / 9:30 am PT
Access: https://attendee.gotowebinar.com/register/607...9315473677
Dr. Pourhassan will be joined by Jacob Lalezari, M.D., Chief Executive Officer of Quest Clinical Research and Bruce Patterson, M.D., Chief Executive Officer and founder of IncellDx, a diagnostic partner and an advisor to CytoDyn, to discuss CytoDyn’s two clinical trials with leronlimab as a treatment for COVID-19.
The livestream presentation will be archived for 30 days and participants are encouraged to go to the above-referenced website 10 minutes prior to the start of the presentation. For anyone unable to attend, a video will be posted on CytoDyn’s website approximately 24 hours after the presentation. The conference sponsor provides corporate visibility services to CytoDyn for a fee.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)